![David Wambeke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Wambeke
No open positions remaining
Net worth: 8 M $ as of 30/07/2026
Profile
David John Wambeke worked at Craig-Hallum Capital Group LLC from 2007 to 2023, including the role of Partner & Managing Director in 2023.
From 2023 to 2025, worked at DiaMedica Therapeutics, Inc. as Chief Business Officer.
Attended the University of Minnesota for undergraduate studies.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/05/2025 | 527,114 ( 0.98% ) | 3 M $ | 30/07/2026 | |
| 31/05/2024 | 527,114 ( -.--% ) | 3 M $ | 30/07/2026 | |
INEO Tech Corp.
 INEO Tech Corp. Advertising/Marketing ServicesCommercial Services Operates location-based advertising, analytics and theft detection platform for retailers 19.93% | 17/06/2026 | 10,374,430 ( 19.93% ) | 757 333 $ | 30/07/2026 |
NeuroOne Medical Technologies Corp.
 NeuroOne Medical Technologies Corp. Medical SpecialtiesHealth Technology Develops thin film electrode technology for epileptic patients 1.92% | 28/02/2026 | 166,667 ( 1.92% ) | 281 667 $ | 30/07/2026 |
Former positions of David Wambeke
| Companies | Position | End |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 30/09/2025 |
Craig-Hallum Capital Group LLC
 Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 28/02/2023 |
Training of David Wambeke
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Craig-Hallum Capital Group LLC
Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- David Wambeke
